Clinical Trial Update: A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intravenous cyclosporine for immunosuppression in de novo liver transplant recipients; results were completed and posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Liver Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2011-01-11